Hydroxyquinoline vaginal and Tafenoquine Succinate (Arakoda)
Determining the interaction of Hydroxyquinoline vaginal and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyquinoline topical
Brand name: Trimo-San
Synonyms: Hydroxyquinoline (vaginal)
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyquinoline vaginal-Tafenoquine Succinate (Krintafel)
- Hydroxyquinoline vaginal-Tafinlar
- Hydroxyquinoline vaginal-Tafluprost
- Hydroxyquinoline vaginal-Tafluprost ophthalmic
- Hydroxyquinoline vaginal-Tagamet
- Hydroxyquinoline vaginal-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Hydroxyurea
- Tafenoquine Succinate (Arakoda)-Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Tafenoquine Succinate (Arakoda)-Hydroxyurea Capsules 500 mg
- Tafenoquine Succinate (Arakoda)-Hydroxyurea Tablets
- Tafenoquine Succinate (Arakoda)-Hydroxyzine
- Tafenoquine Succinate (Arakoda)-Hydroxyzine Capsules